Oxatomide Effects in Follicular Conjunctivitis of Presumed Allergic Cause
作者:
J. Blockeel,
O. Leuridan,
期刊:
Ophthalmologica
(Karger Available online 1980)
卷期:
Volume 181,
issue 3-4
页码: 133-138
ISSN:0030-3755
年代: 1980
DOI:10.1159/000309041
出版商: S. Karger AG
关键词: Ophthalmology;Follicular conjunctivitis;Oxatomide;Allergy;Antiallergic agent;Placebo;Cinnarizine;Itching;Follicles
数据来源: Karger
摘要:
This double-blind study suggests that oxatomide may be considered a first-line alternative in the treatment of allergic follicular conjunctivitis. For 4 weeks 18 patients were treated with oxatomide at a dosage of 30 mg b.i.d. A randomized control group of 17 patients received a placebo. Already after 2 weeks, and more marked after 4 weeks, oxatomide produced a significantly higher reduction of itching and follicles than the placebo, involving a lower use of supplementary antihistamine medication. Globally, an excellent or good result was obtained in 78% of the oxatomide-treated patients but only in 29% of the placebo-treated patients. In the drug group 1 patient had gastrointestinal complaints and 1 felt slightly sleepy.
点击下载:
PDF
(1445KB)
返 回